Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To Evaluate the Safety, Tolerability, Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers: a Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Clinical Study

Next Previous
X
Search
Trial Profile

To Evaluate the Safety, Tolerability, Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers: a Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Clinical Study

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs HPP 737 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Sponsors Newsoara Biopharma

    • Most Recent Events

    • 29 Jun 2021 According to a vTv Therapeutics media release, it will be presenting data from this trial in a poster presentation at the 6th World Psoriasis & Psoriatic Arthritis Conference held virtually June 30 - July 3, 2021 in Stockholm, Sweden.The poster will be added to vTv's website following the presentation and will be available at: https://vtvtherapeutics.com/pipeline/hpp737/
    • 17 Feb 2021 Results presented in a vTv Therapeutics media release.
    • 17 Feb 2021 Status changed from recruiting to completed, according to a vTv Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top